TITLE

Researchers develop model for better testing, targeting of MPNST

PUB. DATE
May 2013
SOURCE
Medical Device Daily;5/24/2013, Vol. 17 Issue 101, Special section p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on a new mouse model for malignant peripheral nerve sheath tumors (MPNST) developed by researchers from the Masonic Cancer Center of the University of Minnesota. The model allows the researchers to discover new genes and gene pathways driving this kind of cancer. An unbiased approach to generate mouse models of MPNST development was used by the researchers to identify genes related to the tumor's development.
ACCESSION #
87881279

 

Related Articles

  • Clinic forms center devoted to tumors of nervous system. Santiago, Raquel // Crain's Cleveland Business;7/24/95, Vol. 16 Issue 30, p9 

    Reports on the Cleveland Clinic Foundation's establishment of the Brain Tumor and Neuro-Oncology Center in Cleveland, Ohio to consolidate research and clinical efforts in studying tumors of the nervous system. Appointment of Gene Barnett as director; Cutting edge studies at the center.

  • Characterization of Mouse tGolgin-1 (Golgin-245/trans-Golgi p230/256 kD Golgin) and Its Upregulation during Oligodendrocyte Development. Cowan, David A.; Gay, Denise; Bieler, Bert M.; Zhao, Huizhen; Yoshino, Atsuko; Davis, James G.; Tomayko, Mary M.; Murali, Ramachandran; Greene, Mark I.; Marks, Michael S. // DNA & Cell Biology;Jul2002, Vol. 21 Issue 7, p505 

    As part of an effort to identify gene products that are differentially regulated during oligodendrocyte development, we isolated a mouse cDNA that encodes tGolgin-1, a homolog of the human protein known as golgin-245, trans-golgi p230, or 256 kD golgin. Human tGolgin-1 is the target of...

  • A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation. Caren, Helena; Ejeskar, Katarina; Fransson, Susanne; Hesson, Luke; Latif, Farida; Sjoberg, Rose-Marie; Krona, Cecilia; Martinsson, Tommy // Molecular Cancer;2005, Vol. 4, p10 

    Background: A common feature of neuroblastoma tumours are partial deletions of the short arm of chromosome 1 (1p-deletions). This is indicative of a neuroblastoma tumour suppressor gene being located in the region. Several groups including our have been studying candidate neuroblastoma genes in...

  • Medulloblastoma: a potpourri of distinct entities. Pfister, Stefan // Acta Neuropathologica;Apr2012, Vol. 123 Issue 4, p463 

    An introduction is presented in which the author discusses various reports within the issue on topics including the classification of World Health Organization (WHO) to central nervous system (CNS) tumors, medulloblastoma gene expression, and sonic hedgehog (SHH)-driven medulloblastoma.

  • A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region. Baysal, Bora E; Willett-Brozick, Joan E; Taschner, Peter EM; Dauwerse, J G; Devilee, Peter; Devlin, B // European Journal of Human Genetics;Feb2001, Vol. 9 Issue 2, p121 

    Chromosomal region 11q22-q23 is a frequent target for deletion during the development of many solid tumour types, including breast, ovary, cervix, stomach, bladder carcinomas and melanoma. One of the most commonly deleted subregions contains the SDHD gene, which encodes the small subunit of...

  • MOLECULAR ABNORMALITIES OF HSNF5/INI1 GENE IN ATYPICAL TERATOID/RHABDOID TUMORS. Zakrzewska, M.; Wójcik, I.; Zakrzewski, K.; Polis, L.; Fiks, T.; Liberski, P. P. // Folia Neuropathologica;2005, Vol. 43 Issue 3, p225 

    This article presents an abstract of the research paper "Molecular Abnormalities of HSNF5/INI1 Gene in Atypical Teratoid/Rhabdoid Tumors," which was discussed in the 13th Conference of the Polish Association of Neuropathologist. Atypical teratoid/rhabdoid tumor represents about 2% of pediatric...

  • Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours. Mora, J.; Alaminos, M.; de Torres, C.; Illei, P.; Qin, J.; Cheung, N.-K. V; Gerald, W. L. // British Journal of Cancer;9/13/2004, Vol. 91 Issue 6, p1112 

    Chromosome 9p21 is frequently deleted in many cancers. Previous reports have indicated that 9p21 LOH is an uncommon finding in neuroblastoma (NB), a tumour of childhood. We have performed an extensive analysis of 9p21 and genes located in this region (cyclin-dependent kinase inhibitor...

  • Growth Factors in Gliomas Revisited. Hamel, W.; Westphal, M. // Acta Neurochirurgica;Feb2000, Vol. 142 Issue 2, p113 

    Summary¶ Overexpression or untimely expression of wild-type or mutated protein growth factors and their receptors is associated with the biology of malignant gliomas and other types of cancer. It may result in unchecked tumour cell proliferation, migration/invasion into normal tissue, tumour...

  • An Overview of Gene Therapy Approaches to Neurological Malignancies. Izquierdo, M.L. // BioDrugs;1998, Vol. 9 Issue 4, p337 

    Tumour development is a disease of both somatic and genetic origin. It originates from a combination of oncogene and tumour suppressor alterations that force the cell into unprogrammed proliferation. It is reasonable to think that a genetic disease could be cured by gene therapy, and several...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics